Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOMENTUM: Early Model-Informed Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children
NCT06929702Phase 4Recruiting
- Sponsor
- Ghent University Hospital
- Start
- Jul 2025
- Primary completion
- Oct 2027
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin + clavulanate, piperacillin + tazobactam, meropenem in systemic infection, sponsored by Ghent University Hospital. Started Jul 2025; status: recruiting.
02
Drugs
amoxicillin + clavulanatepiperacillin + tazobactammeropenem
03
Conditions
systemic infection
Beyond the preview
Go deeper on NCT06929702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06929702.